טוען...
Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome
Myelodysplastic syndrome (MDS) is an aggressive and genetically heterogeneous disease with poor prognosis. Cellular immune disorder is a common characteristic of this disease and is thought to be related to clinical outcome. Alterations in T cell clonal expansion and T cell dysfunction has been dete...
שמור ב:
| הוצא לאור ב: | Biomark Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8193904/ https://ncbi.nlm.nih.gov/pubmed/34112264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-021-00302-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|